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Arylalkylamine N-acyltransferase-like 22 (AANATL2) from Drosophila melanogasterwas expressed and
shown to catalyze the formation of long-chain N-acylserotonins and N-acydopamines. Subsequent
identiﬁcation of endogenous amounts of N-acylserotonins and colocalization of these fatty acid
amides and AANATL2 transcripts gives supporting evidence that AANATL2 has a role in the biosynthetic
formation of these important cell signalling lipids.
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Fatty acid amides are an emerging class of cell signalling lipids.
This family of bioactive amides consists of N-acyl amino acids,
N-acylarylalkylamines, N-acylethanolamides, N-monoacylpolyam-
ines, and primary fatty acid amides. The N-acylarylalkylamides
can be subdivided into two groups called the N-acyldopamines
and the N-acylserotonins. With the exception of the N-acylethanol-
amines, the biosynthetic routes to these long-chain fatty acid
amides in vivo is largely unknown [1,2].The N-acylserotonins were originally synthesized as inhibitors
of fatty acid amino hydrolase (FAAH), the primary focus being
N-arachidonoylserotonin with an IC50 = 12 lM [3]. Following this
discovery, N-arachidonoylserotonin was shown to act as a vanilloid
TRPV1 receptor antagonist [4], as an inhibitor of soybean lipoxyge-
nase [5], as a regulator for gastric emptying [6], and also exhibited
analgesic, anxiolytic, and anti-allergic activity in various model
systems [4,7–8]. The biological roles for the other known long-
chain N-acylserotonins have yet to be determined. Recently,
Verhoeckx et al. [9] identiﬁed and quantiﬁed the endogenous
amounts of long-chain N-acylserotonins in the different regions
of the porcine gastrointestinal tract, including the ileum. Like the
N-acylserotonins, activities have been ascribed to the N-acyldop-
amines, as the N-acyldopamines regulate pain perception, body
temperature, and locomotion in mammals [10–13]. Little is known
about the in vivo production of the N-acylserotonins and N-acyl-
dopamines except for data showing that these could be produced
by the direct conjugation of serotonin or dopamine to a fatty acid
[9,14]. One set of biosynthetic reactions consistent with these data
would be the initial formation of the acyl-CoA in a reaction requir-
ing adenosine triphosphate (ATP), followed by a reaction between
the resulting acyl-CoA and serotonin or dopamine to form the
long-chain N-acylarylalkylamide (Fig. 1). Acyl-CoA formation is
catalyzed by an acyl-CoA synthetase, a known enzyme [15], while
Fig. 1. Proposed reaction for the formation of long-chain N-acylserotonins catalyzed by AANATL2.
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the ﬁrst time. This chemistry is consistent with reactions catalyzed
by the arylalkylamine N-acetyltransferases (AANATs) and other
enzymes of the GCN5-related N-acetyltransferase (GNAT) family
enzymes [16–18].
AANATs from a number of organisms have been shown to cata-
lyze the production of different N-acetylarylalkylamides like
N-acetyldopamine and N-acetylserotonin [16–18]. Other than a
single report that propionyl-CoA and butyryl-CoA are relatively
poor substrates for human serotonin N-acetyltransferase [19],
it has not been determined if the known AANATs will utilize
long-chain acyl-CoA thioesters as substrates to generate the corre-
sponding long chain N-acylarylalkylamides [19]. Eight putative
arylalkylamine N-acetyltransferase-like (AANATL) enzymes [20]
were identiﬁed in Drosophila melanogaster and we hypothesized
that one of these enzymes would have a role in the formation of
the long-chain N-acylserotonins.
Herein, we provide evidence that arylalkylamine N-acyltrans-
ferase like 2 (AANATL2), an AANATL enzyme from Drosophila
melanogaster (D. melanogaster) (CG9486), will catalyze the forma-
tion of long-chain N-acylserotonins. We further deﬁne the expres-
sion of AANATL2 transcripts in different anatomical regions of the
ﬂies and ﬁnd measureable levels of the endogenous N-acylseroto-
nins in regions that overlap with the expression of the AANATL2
transcripts. While the N-acylserotonins are the major focus of this
report, we also demonstrate that arylalkylamines other than sero-
tonin are AANATL2 substrates, including dopamine, octopamine,
and tyramine. These data suggest that AANATL2 could serve
broadly in the cellular production of numerous different
N-acylarylalkylamides.
2. Materials and methods
2.1. Materials
Codon optimized AANATL2 was purchased from Genscript.
Oligonucleotides were purchased from Euroﬁns MWG Operon.
BL21(DE3) Escherichia coli competent cells and pET-28a(+) vector
were purchased from Novagen. Probond™ nickel-chelating resin,
Ambion MicroPoly(A) Purist, and Ambion Retroscript kit were pur-
chased from Invitrogen. NdeI, XhoI, Antarctic Phosphatase, and T4
DNA ligase were purchased from New England Biolabs. Ampicillin
sodium salt and IPTG were purchased from Gold Biotechnology.
Long-chain acyl-CoAs were purchased from Sigma–Aldrich.
D. melanogaster (Oregon R) and 4–24 Instant Medium were sup-
plied by Carolina Biological. Silica was purchased from Suppelco.
Long-chain N-acylserotonins and N-arachidonoylglycine-d8
standards were purchased from Cayman Chemical. All other
reagents were of the highest quality available from either
Sigma–Aldrich or Fisher Scientiﬁc.
2.2. Molecular cloning
2.2.1. AANATL2
(CG9486; Accession No. NM_135161.3) was codon optimized
for expression in Escherichia coli (E. coli) and purchased fromGenscript. The codon optimized gene was inserted into a pET28a(+)
vector using the NdeI and XhoI restriction sites. The AANATL2-
pET28a vector was then transformed into E. coli BL21(DE3) compe-
tent cells and plated on a LB agar plate supplemented with
40 lg/mL kanamycin. A single colony from the transformation
was then used for the expression of AANATL2.
2.3. Protein expression and puriﬁcation
The BL21(DE3) E. coli cells containing the D. melanogaster
AANATL2-pET28a vector were cultured in LB media supplemented
with 40 lg/mL kanamycin and induced with 1 mM isopropyl
b-D-1-thiogalactopyranoside at an OD600 of 0.6 for 4 h at 37 C.
The ﬁnal culture was then harvested by centrifugation at 5000g
for 10 min at 4 C and the pellet was collected.
The pellet was then resuspended in 20 mM Tris, 500 mM NaCl,
5 mM imidazole; lysed by sonication; and then centrifuged at
10000g for 15 min at 4 C. The resulting supernatant was loaded
onto 6 mL of Probond™ nickel-chelating resin. The column was
ﬁrst washed with 10 column volumes of 20 mM Tris–HCl,
500 mM NaCl, 5 mM imidazole, pH 7.9, then washed with 10 col-
umn volumes of 20 mM Tris–HCl, 500 mM NaCl, 60 mM imidazole,
pH 7.9, and lastly eluted in 1 mL fractions of 20 mM Tris–HCl,
500 mM NaCl, 500 mM imidazole, pH 7.9. The AANATL2 within
these fractions were analyzed for purity using a 10% sodium dode-
cyl sulfate polyacrylamide gel electrophoresis (SDS–PAGE) gel,
visualized using Coomassie stain, and pooled together. The pooled
fractions are dialyzed overnight at 4 C in 20 mM Tris, 200 mM
NaCl, pH 7.4 and stored at 80 C.
2.4. Activity assay
Steady-state kinetic characterization of AANATL2 was per-
formed in 300 mM Tris–HCl, pH 8.0, 150 lM 5,50-dithiobis(2-nitro-
benzoic acid) (DTNB) [21], and varying concentrations of
substrates. Initial rates were measured continuously at 412 nm. Ki-
netic constants for long-chain acyl-CoA substrates were deter-
mined by holding the initial serotonin concentration constant at
5 mM. Kinetic constants for the short-chain acyl-CoA substrates,
acetyl-CoA and butyryl-CoA, were determined by holding the ini-
tial serotonin concentration constant at 100 lM. The steady-state
kinetic constants for serotonin, dopamine, octopamine, and tyra-
mine were delineated by holding the initial acyl-CoA concentration
at 50 lM. Steady-state kinetic constants were obtained by ﬁtting
the data to the Michaelis–Menten equation in SigmaPlot 12.0.
2.5. AANATL2 product characterization
The product of the AANATL2-catalyzed reaction was generated
by incubating 36 lg of the enzyme for 1 h in 300 mM Tris–HCl,
pH 8.0, 50 mM serotonin or dopamine, and 500 lM oleoyl-CoA.
The reaction mixture was passed through a 10 kDa ultraﬁlter (Mil-
lipore) to remove the AANATL2 and resulting protein-free solution
injected on an Agilent 6540 liquid chromatography/quadrupole
time-of-ﬂight mass spectrometer (LC/QTOF-MS) in positive ion
mode. A Kinetex™ 2.6 lm C18 100 Å (50  2.1 mm) reverse phase
Fig. 2. SDS-PAGE analysis of puriﬁed D. melanogaster AANATL2. Left lane is
PageRuler™ Prestained Protein Ladder. Right lane is puriﬁed AANATL2.
Table 1
Acyl-CoA speciﬁcity for AANATL2.
Substratea (KM,acyl-CoA)app (kcat,acyl-CoA)app (kcat/KM)acyl-CoA,app
lM s1 M1 s1
Acetyl-CoA 6.1 ± 0.27 1.3 ± 0.012 (2.2 ± 0.020)  105
Butyryl-CoA 1.8 ± 0.17 0.53 ± 0.011 (2.9 ± 0.058)  105
Palmitoyl-CoA 9.9 ± 1.6 0.16 ± 0.0090 (1.6 ± 0.091)  104
Stearoyl-CoA 6.0 ± 0.75 0.059 ± 0.0023 (9.8 ± 0.39)  103
Oleoyl-CoA 3.6 ± 0.58 0.075 ± 0.0033 (2.1 ± 0.091)  104
Arachidonoyl-CoA 1.9 ± 0.25 0.043 ± 0.0013 (2.3 ± 0.068)  104
a Background rates of acyl-CoA hydrolysis were obtained at each CoA concen-
tration in the absence of serotonin and subtracted from the rate obtained in the
presence of serotonin. The non-serotonin background rates were 615% of rates
obtained in the presence of serotonin, with exception of steroyl-CoA. For stearoyl-
CoA, the background hydrolysis rates were 630%.
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consisted of water with 0.1% formic acid and mobile phase B con-
sisted of acetonitrile with 0.1% formic acid. A linear gradient of 10%
B increasing to 100% B over the course of 5 min, followed by a hold
of 3 min at 100% B was used for the LC analysis of the reaction
product. The reverse phase column was equilibrated with 10% B
for 8 min after the run to prepare the column for the subsequent
injections.
2.6. AANATL2 transcript localization
D. melanogaster were grown on 4–24 Instant Medium from
Carolina Biological, ﬂash frozen for decapitation, and the heads
were separated from thorax-abdomens using a wired mesh. Ambi-
on MicroPoly(A) Purist kit was used to purify the mRNA and Ambi-
on Retroscript kit was used to generate the cDNA library for
subsequent reverse transcription polymerase chain reaction
(RT-PCR) localization of AANATL2 from D. melanogaster head and
thorax-abdomen. Identiﬁcation of AANATL2 transcripts was com-
pleted by RT-PCR (45 cycles of 95 C for 30 s; 60 C for 30 s;
72 C for 1 min). The primers used to amplify a 247 bp region
of AANATL2 (forward – ATGACAATCGGGGATTACGA, reverse –
CCTCCTGGTACTCCCTCTCC) were designed and synthesized by
Euroﬁns MWG Operon. Ampliﬁed product from the RT-PCR reac-
tion was analyzed by a 0.6% agarose gel and the band visualized
by 0.5 lg/mL ethidium bromide under ultraviolet light. The posi-
tive bands at 247 bp were cut out of the gel, puriﬁed by the Prome-
ga Wizard SV Gel and PCR Clean-up system, and sequenced by
Euroﬁns MWG Operon.
2.7. Endogenous quantiﬁcation of long-chain N-acylserotonins
Four separate cultures of D. melanogaster were used for the
analysis of endogenous levels of long-chain N-acylserotonins. Lip-
ids were extracted using organic solvents followed by the solid
phase puriﬁcation of Farrell et al. [22]. The puriﬁed extracts were
dried under N2, reconstituted in HPLC grade methanol, and injected
on an Agilent 1260 connected to an Agilent 6540 LC/QTOF-MS in
positive ion mode. Injected lipid extracts were separated by a Kine-
tex™ 2.6 lm C18 100 Å (50  2.1 mm) reverse phase column at
0.6 mL/min. Mobile phase A consisted of water with 0.1% formic
acid and mobile phase B consisted of acetonitrile with 0.1% formic
acid. A linear gradient was used for the separation of the injected
lipid extracts by reverse phase chromatography starting at 10% B
and increasing to 100% B over the course of 5 min, followed by a
hold of 3 min at 100% B. The reverse phase column was equili-
brated with 10% B for 8 min after the run to prepare the column
for subsequent injections. N-Arachidonoylglycine-d8, 1 pmol per
10 lL injection, was spiked into each extraction to measure instru-
ment performance and for data normalization. The four extractions
from separate cultures of D. melanogaster were analyzed in
triplicate for a total of 12 runs. Standard curves of commercially
available N-acylserotonins and N-arachidonoylglycine-d8 were
analyzed in triplicate with a linear range of 100 fmoles to 5 pmol
(r2 values >0.99).
3. Results and discussion
The codon optimized D. melanogaster AANATL2 gene was
prepared commercially by Genscript and cloned into a pet28a(+)
vector that encodes for an N-terminal His6-tag protein. Recombi-
nant D. melanogaster AANATL2 was expressed in E. coli BL21(DE3)
cells and puriﬁed using Probond™ nickel-chelating resin. The puri-
ﬁed AANATL2 was then analyzed by SDS–PAGE (Fig. 2), yielding a
single band at 25 kDa.Potential substrates for AANATL2 were identiﬁed using Ellman’s
reagent [21] by measuring the acyl-CoA dependent release of
CoA-SH which yields 2-nitro-5-thiobenzoate at 412 nm. Activity
was observed with serotonin and oleoyl-CoA from our substrate
screening studies which was evaluated in greater detail with
subsequent steady-state kinetic analysis of AANATL2 with a set
of acyl-CoA thioesters and serotonin. We found that acyl-CoA
thioesters from acetyl-CoA to arachidonoyl-CoA are AANATL2
substrates with some variability in the apparent kinetic constants
at saturating serotonin. The (KM,acyl-CoA)app values for all the
acyl-CoA thioesters included in our study were approximately
the same, ranging from 2 lM for butyryl-CoA and arachidonoyl-
CoA to10 lM for palmitoyl-CoA. Greater variability was observed
for the (kcat,acyl-CoA)app and (kcat/KM)acyl-CoA,app values with a range of
20–30-fold. Based on our data, the short-chain acyl-CoA thioesters
are, in general, substrates with higher (kcat/KM,acyl-CoA)app values
than the long-chain acyl-CoA thioesters (Table 1). Amherd et al.
[20] expressed D. melanogaster AANATL2 in COS-7 cells and report
a (KM,acyl-CoA)app for acetyl-CoA of 7.2 ± 0.6 lM with tryptamine as
a co-substrate that is similar to the value we measure using
serotonin as the co-substrate. A comparison of (kcat,acyl-CoA)app
and (kcat/KM)acyl-CoA,app values we measure (Table 1) to those
reported by Amherd et al. [20] is difﬁcult as these researchers
did not purify recombinant AANATL2 from the COS-7 cells.
We have also evaluated biologically relevant arylalkylamines
other than serotonin as substrates for AANATL2, namely dopamine,
octopamine, and tyramine. Ahmerd et al. [20] have already demon-
strated that tryptamine is a substrate for D. melanogaster AANATL2.
Neither tyramine nor octopamine were substrates when the acyl
acceptor was oleoyl-CoA as the observed rate of CoA release from
oleoyl-CoA was equivalent to the background rate of hydrolysis
Table 3
Standards used for identiﬁcation of endogenous long-chain N-acylserotonins and the
AANATL2 product characterization.
N-acylarylalkylamide standard Retention time Molecular ion [M+H]+
min m/z
N-oleoylserotonin 6.132 441.3878
N-palmitoylserotonin 6.038 415.3344
N-stearoylserotonin 6.368 443.3620
N-arachidonoylserotonin 5.900 463.3291
N-oleoyldopamine 5.929 418.3326
AANATL2 producta 6.130 441.3464
AANATL2 productb 5.929 418.3325
a Reaction conditions: 300 mM Tris–HCl, pH 8.0, 50 mM serotonin, and 500 lM
oleoyl-CoA was incubated with 36 lg of AANATL2 for 1 h.
b Reaction conditions: 300 mM Tris–HCl, pH 8.0, 50 mM dopamine, and 500 lM
oleoyl-CoA was incubated with 36 lg of AANATL2 for 1 h.
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substrates when the acyl acceptor was acetyl-CoA. The kinetic con-
stants for the AANATL2-catalyzed formation of N-acetyltyramine
and N-acetyloctopamine are similar to those determined for the
formation of N-acetylserotonin except for a relatively high
(KM,amine)app for octopamine of 78 ± 3.9 lM (Table S1, Supplemen-
tary Materials). Dopamine is a substrate for AANATL2 when the
co-substrate is acetyl-, palmitoyl-, or oleoyl-CoA (Table 2). Again,
the kinetic constants for the formation of N-acetyldopamine are
similar to those determined for the generation of the other N-
acetylarylalkylamides.
We evaluated the relationship between the (KM,amine)app for
serotonin or dopamine as a function of acyl chain length for the
acyl-CoA substrates (Table 2) because both of these were sub-
strates when acetyl-CoA and the long-chain acyl-CoA were co-sub-
strates. The pattern in the data was the same for both serotonin
and dopamine, the (KM,amine)app increased, the (kcat,amine)app de-
creased, and the (kcat/KM)amine,app decreased as the acyl chain
length increased from acetyl to arachidonoyl. The ratio of
ðkcat=KMÞacetylCoAamine;app =ðkcat=KMÞarachidonoylCoAamine;app is 3400 for dopamine and
5000 for serotonin indicating that acetyl-CoA is substantially
preferred by AANATL2. Side-by-side comparisons of the acyl-CoA
thioesters between serotonin and dopamine show that AANATL2
exhibits a slight preference for serotonin as the amine donor
substrate.
An examination of our kinetic data reveals some patterns: (a)
limited variation in the (KM,acyl-CoA)app values for the acyl-CoA sub-
strates as all are in the range of 2–10 lM, (b) limited variation
(kcat,amine)app and (kcat/KM)amine,app values on the amine substrate,
(c) an increase in the (KM,amine)app values for the amine substrates
as the length of the acyl chain increases for the acyl-CoAs, and
(d) a decrease in the (kcat,amine)app and (kcat/KM)amine,app values as
the length of the acyl chain increases for the acyl-CoAs. These data
suggest that the long-chain acyl group either interferes with the
binding of the arylalkylamine substrates or that the binding of
the long-chain acyl-CoAs results in an AANATL2 conformation that
is less optimal for catalysis. An X-ray structure of AANATL2 with
bound acetyl-CoA or oleoyl-CoA could differentiate between these
two possibilities. We also note the relatively low kcat,app values
[(kcat,acyl-CoA)app and (kcat,amine)app] values for the long-chain acyl-
CoA substrates; however, low kcat,app values are not surprising
since the long-chain N-acyl-serotonins and dopamines likely serve
as potent cell signaling lipids [9–13]. The cellular function of AA-
NATL2 may be the generation of the long-chain N-acylarylalkyla-
mides and the measured kcat,app values are sufﬁcient to supplyTable 2
Apparent kinetic constants for serotonin and dopamine using different acyl-CoA
substrates.
Substratea (KM,amine)app (kcat,amine)app (kcat/KM)amine,app
lM s1 M1 s1
Serotonin
Acetyl-CoA 7.2 ± 1.1 2.4 ± 0.097 (3.3 ± 0.13)  105
Butyryl-CoA 2.9 ± 0.33 0.52 ± 0.011 (1.8 ± 0.040)  105
Palmitoyl-CoA 870 ± 60 0.15 ± 0.0034 (1.7 ± 0.039)  102
Stearoyl-CoA 350 ± 35 0.057 ± 0.0014 (1.6 ± 0.040)  102
Oleoyl-CoA 490 ± 86 0.085 ± 0.0059 (1.7 ± 0.12)  102
Arachidonoyl-CoA 460 ± 69 0.030 ± 0.0014 66 ± 3.0
Dopamine
Acetyl-CoA 0.042 ± 0.0097 6.5 ± 0.67 (1.6 ± 0.16)  105
Palmitoyl-CoA 1.1 ± 0.13 0.14 ± 0.0050 (1.2 ± 0.045)  102
Oleoyl-CoA 1.2 ± 0.20 0.058 ± 0.0033 47 ± 2.7
a Background rates of acyl-CoA hydrolysis were obtained at a saturating CoA
concentration in the absence of the arylalkylamine and subtracted from the rate
obtained in the presence of arylalkylamine. The non-arylalkylamine (background
rates) were 620% of rates obtained in the presence of arylalkylamine.the cellular needs of these potent lipid amides. Saghatelian and
Cravatt [23] have shown in their studies of FAAH(/) that
in vitromeasurements of kinetic constants may not provide a com-
plete understanding of the functional role of an enzyme in vivo.
The products from the AANATL2 catalyzed reaction between
oleoyl-CoA and serotonin or dopamine were positively identiﬁed
as N-oleoylserotonin and N-oleoyldopamine (Table 3). AANATL2
was incubated with serotonin or dopamine and oleoyl-CoA for
1 h, the enzyme was removed by ultraﬁltration using a 10 kDa cut-
off ﬁlter, followed by product analysis by liquid chromatography/
quadrupole time-of-ﬂight mass spectrometry (LC/QTOF-MS). AA-
NATL2-generated N-oleoylserotonin or N-oleoyldopamine was
compared to a commercial standard. Positive identiﬁcation was
delineated by a comparable retention time and molecular ion m/z
for the AANATL2 product and the standard (Table 3).
The in vitro data we obtained using puriﬁed AANATL2 (substrate
speciﬁcity and product characterization) lead to questions such as:
(a) are the long-chain N-acylarylalkylamides found in D. melano-
gaster, (b) if so, what are the steady-state endogenous levels of
these fatty acid amides, and (c) would we ﬁnd colocalization of
endogenous N-acylarylalkylamides and AANATL2? To address
these intriguing questions, we ﬁrst identiﬁed the localization of
the AANATL2 transcripts by RT-PCR. Primers were designed and
synthesized commercially to generate a 247 bp AANATL2-derived
RT-PCR product from the cDNA libraries generated from D. melano-
gaster head and thorax-abdomen. The RT-PCR experiments show
that AANATL2 transcripts were only found in the thorax-abdomen
of D. melanogaster (Fig. 3).Fig. 3. RT-PCR of AANATL2 in D. melanogaster head and thorax-abdomen. Lanes 1–4
is data generated from the D. melanogaster head cDNA library at 45, 50, 55, and
60 C annealing temperatures respectively. Lane 5 is 100 bp DNA ladder from New
England Biolabs. Lanes 6–9 is data generated from the D. melanogaster thorax-
abdomen cDNA library at 45, 50, 55, and 60 C annealing temperature respectively.
Lane 10 is a 1 kb DNA ladder from New England Biolabs.
Table 4
Endogenous amounts of N-acylserotonins found in D. melanogaster head and thorax-abdomen.
N-acylserotonin Heada Thorax-abdomenb
Extracted amount Extracted amount Retention time Molecular ion
pmoles g1 pmoles g1 min [M+H]+ m/z
N-oleoylserotonin ndc 0.42 ± 0.55 6.147 441.2633
6.009 441.2684
6.149 441.2666
6.180 441.2622
N-palmitoylserotonin ndc 1.16 ± 0.12 6.036 415.3249
6.032 415.3237
6.040 415.3243
N-stearoylserotonin ndc 53.5 ± 33.3 6.367 443.3143
6.244 443.2986
6.368 443.3167
6.262 443.2993
N-arachidonoylserotonin ndc 0.25 ± 0.15 5.907 463.2998
5.906 463.3022
5.882 463.3478
5.940 463.3138
a Identiﬁcation and quantiﬁcation of endogenous amounts extracted from 1 g of D. melanogaster heads.
b Identiﬁcation and quantiﬁcation of endogenous amounts extracted from 1 g of D. melanogaster thorax-abdomen.
c nd indicates that these N-acylserotonins were ‘‘not detected’’ in 1 g of this anatomical location of D. melanogaster.
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uct generated from the D. melangaster thorax-abdomen cDNA li-
brary; however, a similar RT-PCR product was not observed from
the head cDNA library. The sequence of the 247 bp product from
the thorax-abdomen library was conﬁrmed as AANATL2 by DNA
sequencing. These data are in slight contrast to the report a faint
band for AANATL2 from D. melanogaster head by Northern analysis
[20]. Together, our data and that from Amherd et al. [20] indicate
that AANATL2 transcripts are found at substantially higher levels
in the thorax-abdomen relative to the head in D. melanogaster.
Our identiﬁcation of the AANATL2 transcripts in the thorax-
abdomen and the relatively high levels of serotonin in the mam-
malian gastrointestinal tract [9,24] strongly suggested to us that
the long-chain N-acylserotonins would exist endogenously in the
thorax-abdomen of D. melanogaster. Four long-chain N-acylseroto-
nins were identiﬁed in the thorax-abdomen by molecular ion m/z
and retention time comparisons to commercially available stan-
dards (Table 4) by LC/QTOF-MS in positive ion mode. Endogenous
amounts of N-acylserotonins were not identiﬁed in the heads, con-
sistent with our RT-PCR data in which the AANATL2 transcripts
were not found. Standard curves with a linear range of 100 fmoles
to 5 pmol (r2 values >0.99) were used to quantify the endogenous
amounts of N-acylserotonins in the thorax-abdomen. N-Stearoylse-
rotonin was the most abundant followed by N-palmitoylserotonin,
N-arachidonoylserotonin, and N-oleoylserotonin (Table 4). The
N-acylserotonin levels that we found in the thorax-abdomen of
D. melanogaster are similar to that reported for these fatty acid
amides in porcine gastrointestinal tract [9]. In contrast to the
long-chain N-acylserotonins, the long-chain N-acyldopamines are
found in both the thorax-abdomen and the heads of
D. melanogaster [25]. The dissimilarities in the localization of the
long-chain N-acylserotonins relative to the long-chain
N-acyldopamines are likely the result of differences in
biosynthesis, degradation, and/or transport of these different
N-acylarylalkylamides.
In summary, AANATL2 from D. melanogaster was shown to
catalyze the formation of a diverse set of N-acylarylalkylamides
with the most intriguing products being the long-chain
N-acylserotonins and N-acyldopamines. Colocalization of AANATL2
transcripts and endogenous long-chain N-acylserotonins to the
thorax-abdomen points to an important role for this enzyme in
the biosynthesis of these cell signalling long-chainN-acylarylalkylamides. Future work to expand our understanding
of biosynthesis and degradation of the N-acylserotonins,
N-acyldopamines, and other long-chain N-acylarylalkylamides
involving the inhibition of key enzymes is ongoing.
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